Haemonetics Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for Haemonetics stock have an average target of 103.56, with a low estimate of 85 and a high estimate of 116. The average target predicts an increase of 64.33% from the current stock price of 63.02.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$85	$103.56	$108	$116
Change	+34.88%	+64.33%	+71.37%	+84.07%

Analyst Ratings

The average analyst rating for Haemonetics stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	3	3	4	4	4	4
Buy	2	2	2	3	3	3
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	8	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andrew Cooper Raymond James	Raymond James	Strong Buy Reiterates $120 → $115	Strong Buy	Reiterates	$120 → $115	+82.48%	Feb 7, 2025
David Turkaly JMP Securities	JMP Securities	Buy Maintains $125 → $100	Buy	Maintains	$125 → $100	+58.68%	Feb 7, 2025
Mike Matson Needham	Needham	Strong Buy Maintains $112 → $108	Strong Buy	Maintains	$112 → $108	+71.37%	Feb 7, 2025
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $108 → $95	Buy	Maintains	$108 → $95	+50.75%	Feb 7, 2025
Rohin Patel JP Morgan	JP Morgan	Buy Initiates $116	Buy	Initiates	$116	+84.07%	Dec 6, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

1.41B

from 1.31B

7.56%

from 1.31B

Revenue Next Year

1.45B

from 1.41B

3.13%

from 1.41B

EPS This Year

4.59

from 2.29

100.49%

from 2.29

EPS Next Year

5.06

from 4.59

10.14%

from 4.59

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 28, 2020	Apr 3, 2021	Apr 2, 2022	Apr 1, 2023	Mar 30, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	988.48M	870.46M	993.20M	1.17B	1.31B	1.41B	1.45B	1.58B
Revenue Growth	2.16%	-11.94%	14.10%	17.67%	12.01%	7.56%	3.13%	9.09%
EPS	1.48	1.55	0.84	2.24	2.29	4.59	5.06	5.82
EPS Growth	42.31%	4.73%	-45.81%	166.67%	2.23%	100.49%	10.14%	15.18%
Forward PE	-	-	-	-	-	13.73	12.46	10.82
No. Analysts	-	-	-	-	-	11	11	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	1.5B	1.6B	1.7B
Avg	1.4B	1.5B	1.6B
Low	1.4B	1.4B	1.5B

Revenue Growth

Revenue Growth	2025	2026	2027
High	12.3%	10.3%	17.4%
Avg	7.6%	3.1%	9.1%
Low	3.7%	-2.5%	2.5%

EPS Forecast

EPS	2025	2026	2027
High	4.85	5.47	6.30
Avg	4.59	5.06	5.82
Low	4.41	4.56	5.34

EPS Growth

EPS Growth	2025	2026	2027
High	111.8%	19.2%	24.6%
Avg	100.5%	10.1%	15.2%
Low	92.6%	-0.7%	5.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.